NANO — Nanobiotix SA Balance Sheet
0.000.00%
Last trade - 00:00
- €247.57m
- €220.39m
- €30.06m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 35.1 | 119 | 83.9 | 41.4 | 75.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8.36 | 3.88 | 6.93 | 7.99 | 9.49 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 46.1 | 125 | 93.1 | 52.4 | 87.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.39 | 8.26 | 8.19 | 7.12 | 6.25 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 56.2 | 134 | 102 | 59.8 | 93.9 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 14.3 | 19 | 36.8 | 37.9 | 49.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 58.1 | 63.6 | 75 | 86.8 | 95.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -1.91 | 70.5 | 26.8 | -27 | -1.84 |
Total Liabilities & Shareholders' Equity | 56.2 | 134 | 102 | 59.8 | 93.9 |
Total Common Shares Outstanding |